Cenra Inc. — Investor Relations & Filings
Cenra Inc. is a diversified healthcare enterprise with a history dating back to 1952. The company operates across a comprehensive value chain encompassing research and development, manufacturing, commercial marketing, and long-term care services. Its extensive portfolio includes active pharmaceutical ingredients (APIs), human pharmaceuticals, animal health products, and consumer health brands such as dietary supplements and personal care items. With a global reach spanning over 60 markets, the organization utilizes nine production bases and more than ten specialized technology platforms to deliver integrated health solutions. Cenra Inc. focuses on high-barrier oncology medications, complex generics, and 505(b)(2) drug developments. By integrating scientific innovation with rigorous operational management, the company provides accessible medical care and health services designed to meet evolving needs across all life stages.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 公告本公司董事會決議發行限制員工權利新股 | 2026-03-05 | Chinese | |
| 公告本公司董事會決議不繼續辦理 114年股東常會通過之私募有價證券案 | 2026-03-05 | Chinese | |
| 本公司召開115年股東常會相關事宜。 | 2026-03-05 | Chinese | |
| 115年02月董事會成員及持股 | 2026-03-05 | Chinese | |
| 115年02月內部人持股異動(事後) | 2026-03-05 | Chinese | |
| 代子公司「中國化學製藥股份有限公司」公告 其董事會通過員工酬勞及董監事酬勞分派議案 | 2026-03-04 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 34529185 | 公告本公司董事會決議發行限制員工權利新股 | 2026-03-05 | Chinese | ||
| 34529187 | 公告本公司董事會決議不繼續辦理 114年股東常會通過之私募有價證券案 | 2026-03-05 | Chinese | ||
| 34529188 | 本公司召開115年股東常會相關事宜。 | 2026-03-05 | Chinese | ||
| 34529193 | 115年02月董事會成員及持股 | 2026-03-05 | Chinese | ||
| 34529189 | 115年02月內部人持股異動(事後) | 2026-03-05 | Chinese | ||
| 34529194 | 代子公司「中國化學製藥股份有限公司」公告 其董事會通過員工酬勞及董監事酬勞分派議案 | 2026-03-04 | Chinese | ||
| 34529196 | 代本公司重要子公司中國化學製藥股份有限公司 公告其董事會決議發放114年度股利 | 2026-03-04 | Chinese | ||
| 34529197 | 代子公司「蘇州中化藥品工業有限公司」公告其董事會 決議不發放114年度股利 | 2026-03-03 | Chinese | ||
| 34529198 | 公告本公司114年度財務報告董事會預計召開日期為 115年3月5日 | 2026-02-25 | Chinese | ||
| 34529200 | 代子公司「中化裕民健康事業股份有限公司」公告 其董事會通過員工酬勞及董監事酬勞分派議案 | 2026-02-23 | Chinese | ||
| 34529202 | 代本公司重要子公司中化裕民健康事業股份有限公司 公告其董事會決議發放114年度股利 | 2026-02-23 | Chinese | ||
| 34529205 | 115年1月背書保證與資金貸與 | 2026-02-10 | Chinese | ||
| 34529204 | 115年1月營業收入 | 2026-02-10 | Chinese | ||
| 34529211 | 115年01月內部人持股異動(事後) | 2026-02-05 | Chinese | ||
| 34529208 | 115年01月董事會成員及持股 | 2026-02-05 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Cenra Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/52378/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=52378 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=52378 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=52378 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 52378}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Cenra Inc. (id: 52378)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.